Both worthless and simply precursors to disqualify you from a diagnosis if you respond positively. 😉
September 3
How do low dose naltrexone (LDN) and sulfasalazine compare for managing axial spondylitis?
Low dose naltrexone (LDN) is an interesting one — it's not currently an established or approved treatment for axial spondylitis, so there's limited clinical evidence to draw from in this context. It's worth discussing with your Show Full Answer
How do low dose naltrexone (LDN) and sulfasalazine compare for managing axial spondylitis?
Low dose naltrexone (LDN) is an interesting one — it's not currently an established or approved treatment for axial spondylitis, so there's limited clinical evidence to draw from in this context. It's worth discussing with your rheumatologist if you're curious, but it wouldn't typically be a first or second-line recommendation.
Sulfasalazine, on the other hand, is a more recognized option in spondylitis care, though it does come with some important caveats:
- It is not officially approved for axial spondylitis but is sometimes prescribed off-label
- It works better for peripheral joint involvement (joints outside the spine) rather than spinal symptoms
- It may be considered when biologics like TNF inhibitors aren't suitable
- It's taken as an oral tablet
- Common side effects include headache, nausea, indigestion, vomiting, and reversible male infertility
- It's a sulfa-based antibiotic, so those with a sulfa allergy should avoid it The bottom line is that sulfasalazine has at least some evidence and clinical use behind it for axial spondylitis, while LDN doesn't yet have established support in this area. A conversation with your rheumatologist would be the best way to weigh these options based on your specific symptoms and treatment history.
August 19
Join
Your Privacy Choices
